Anupam Rasayan commercializes ETFA production
Analysis based on 6 articles · First reported Jun 11, 2026 · Last updated Jun 12, 2026
The commercialization of ETFA by Anupam Rasayan India using continuous flow chemistry is expected to positively impact the specialty chemicals market by introducing a more efficient and environmentally friendly production method. This innovation could lead to increased demand for ETFA in pharmaceuticals and life sciences, potentially benefiting Anupam Rasayan India's market share and stock performance.
Anupam Rasayan India has achieved a global first by commercializing the production of Ethyl trifluoroacetate (ETFA) using its proprietary continuous flow chemistry platform. This advanced method offers significant advantages over traditional batch processes, including enhanced safety, superior reproducibility, improved scalability, higher operational efficiency, and a lower environmental footprint. ETFA is a critical fluorinated building block used extensively in pharmaceuticals, life sciences, and performance materials, with a global market estimated at USD 500-600 million. This milestone reinforces Anupam Rasayan India's technological capabilities and innovation strategy, as stated by its Managing Director, Anand Desai.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard